Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
Top Cited Papers
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 364 (9435) , 685-696
- https://doi.org/10.1016/s0140-6736(04)16895-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Is Diabetes Mellitus a Cardiovascular Disease Risk Equivalent for Fatal Stroke in Women?Stroke, 2003
- Cholesterol, coronary heart disease, and stroke in the Asia Pacific regionInternational Journal of Epidemiology, 2003
- Stroke subtype and mortalitya follow-up study in 998 patients with a first cerebral infarctJournal of Clinical Epidemiology, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- UKPDS 60Stroke, 2002
- Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesDiabetic Medicine, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Impact of Diabetes on Survival Among Patients With First Myocardial InfarctionDiabetes Care, 1997
- Factors determining case fatality in myocardial infarction "who dies in a heart attack"?Heart, 1995
- Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimensThe American Journal of Cardiology, 1995